CVS Health Corporation
General ticker "CVS" information:
- Sector: Health Care
- Industry: Medical - Healthcare Plans
- Capitalization: $82.7B (TTM average)
CVS Health Corporation follows the US Stock Market performance with the rate: 45.6%.
Estimated limits based on current volatility of 1.7%: low 78.91$, high 81.70$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends (quarterly): last record date 2026-01-22, amount 0.67$ (Y3.41%)
- Total employees count: 300000 (0.0%) as of 2024
- Top business risk factors: Economic downturns and volatility, Cybersecurity threats, Healthcare cost pressures, Market competition, Litigation risks
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [70.21$, 106.17$]
- 2026-12-31 to 2027-12-31 estimated range: [79.01$, 117.76$]
Financial Metrics affecting the CVS estimates:
- Negative: with PPE of 11.7 at the end of fiscal year the price was high
- Positive: -4.75 < Operating profit margin, % of 2.58
- Positive: 6.64 < Operating cash flow per share per price, % of 10.66
- Positive: 19.40 < Shareholder equity ratio, % of 28.81 <= 42.68
- Positive: -3.43 < Return on assets ratio (scaled to [-100,100]) of 0.66
- Positive: Interest expense per share per price, % of 3.13 <= 3.28
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Industry earnings per price (median), % of 5.08 > 4.49
- Positive: Inventory ratio change, % of -0.08 <= 0
- Positive: -14.22 < Investing cash flow per share per price, % of -5.88
Short-term CVS quotes
Relationship graph
Long-term CVS plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $357,776.00MM | $372,709.00MM | $402,067.00MM |
| Operating Expenses | $344,033.00MM | $364,193.00MM | $391,682.00MM |
| Operating Income | $13,743.00MM | $8,516.00MM | $10,385.00MM |
| Non-Operating Income | $-2,570.00MM | $-2,368.00MM | $-8,249.00MM |
| Interest Expense | $2,658.00MM | $2,958.00MM | $3,119.00MM |
| Income(Loss) | $11,173.00MM | $6,148.00MM | $2,136.00MM |
| Taxes | $2,805.00MM | $1,562.00MM | $408.00MM |
| Profit(Loss)* | $8,344.00MM | $4,614.00MM | $1,768.00MM |
| Stockholders Equity | $76,461.00MM | $75,560.00MM | $75,214.00MM |
| Inventory | $18,025.00MM | $18,107.00MM | $19,246.00MM |
| Assets | $249,728.00MM | $253,215.00MM | $261,064.00MM |
| Operating Cash Flow | $13,426.00MM | $9,107.00MM | $10,639.00MM |
| Capital expenditure | $3,031.00MM | $2,781.00MM | $2,832.00MM |
| Investing Cash Flow | $-20,889.00MM | $-7,613.00MM | $-5,871.00MM |
| Financing Cash Flow | $2,683.00MM | $-1,135.00MM | $-4,940.00MM |
| Earnings Per Share** | $6.49 | $3.66 | $1.40 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.